On June 15, 2021 Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, reported that Chief Executive Officer, Bill Newell, will participate in two virtual investor conferences in June (Press release, Sutro Biopharma, JUN 15, 2021, View Source [SID1234584017]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details
JMP Securities Life Sciences Conference

Format: Fireside Chat

Date: Thursday, June 17, 2021

Time: 3:30 p.m. ET / 12:30 p.m. PT

Raymond James Human Health Innovations Conference

Format: Panel Session

Panel Title: Targeted Oncology 2: Antibody Drug Conjugates

Date: Wednesday, June 23, 2021

Time: 10:40 a.m. ET / 7:40 a.m. PT

Live webcasts of each presentation can be accessed through the Events and Presentations page of the Investor Relations section on the company’s website at www.sutrobio.com. Archived replays of the webcasts will be available on the company’s website for approximately 30 days following each live presentation.